New Research from the CWMH: Preliminary Data on the Reproductive Safety of Buspirone (BuSpar)
Although a small sample, no major malformations were observed in a prospectively followed cohort of women with first trimester exposure to buspirone.
Accumulating Data on the Reproductive Safety of Second-Generation, Atypical Antipsychotics, But Still Not Enough
In a cohort of 351 children exposed to second generation antipsychotic during pregnancy, the risk of major congenital malformations did not differ from a comparison group of non-exposed children.
Essential Reads: What is the Best Screening Tool for Depression During Pregnancy?
Many women experience depression during pregnancy. What is the best way to identify these women?
Reassuring News: Neurodevelopmental Outcomes in Two-Year Olds with Prenatal Exposure to Lamotrigine (Lamictal)
These findings are encouraging and suggest that the newer AEDs, specifically lamotrigine and levetiracetam, are not associated with worse neurodevelopmental outcomes.
Essential Reads: Long-Term Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antidepressants
While questions and controversies remain, the information on long-term neurodevelopmental outcomes in children prenatally exposed to antidepressants is largely reassuring.
Essential Reads: Lamotrigine (Lamictal) Dosing During Pregnancy
About 60% of women with mood disorders experience premenstrual exacerbation or PME of their mood during the premenstrual phase of their cycle.
Essential Reads: What is the Best Antidepressant to Use During Pregnancy?
The reality is that most of the antidepressants taken by women today are relatively safe and carry a very low risk to the developing fetus.
Modafinil and Armodafinil During Pregnancy: Data to Suggest Increased Risk of Malformations
As soon as we published this article on the use of modafinil during pregnancy, another study was published which included data on the reproductive safety of modafinil and armodafinil from the US Provigil/Nuvigil Pregnancy [...]